tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

OLMA Stock Latest News

Positive Outlook on Olema Pharmaceuticals Driven by Promising Phase II Trial Results and Upcoming Phase III Initiation
RatingsPositive Outlook on Olema Pharmaceuticals Driven by Promising Phase II Trial Results and Upcoming Phase III Initiation
4d ago
OLMA
Olema Oncology Reports 2024 Financial and Clinical Progress
PremiumCompany Announcements
Olema Oncology Reports 2024 Financial and Clinical Progress
7d ago
OLMA
Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals
PremiumRatings
Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals
9d ago
OLMA
Olema Oncology price target lowered to $25 from $30 at Oppenheimer
PremiumThe Fly
Olema Oncology price target lowered to $25 from $30 at Oppenheimer
9d ago
OLMA
Olema Oncology reports Q4 EPS (51c), consensus (63c)
PremiumThe Fly
Olema Oncology reports Q4 EPS (51c), consensus (63c)
9d ago
OLMA
Oppenheimer biotech analyst holds an analyst/industry conference call
PremiumThe FlyOppenheimer biotech analyst holds an analyst/industry conference call
10d ago
AZN
LLY
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating
Premium
Ratings
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating
17d ago
OLMA
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating
21d ago
OLMA
Olema updated palazestrant combination trial, says Oppenheimer
PremiumThe Fly
Olema updated palazestrant combination trial, says Oppenheimer
23d ago
OLMA
Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating
PremiumRatings
Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating
23d ago
OLMA
Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline
PremiumCompany Announcements
Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline
23d ago
8K
OLMA
OLMA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OLMA Earnings this Week: How Will it Perform?
27d ago
OLMA
Promising Developments in Olema Pharmaceuticals’ Breast Cancer Treatment Drive Buy Rating
PremiumRatingsPromising Developments in Olema Pharmaceuticals’ Breast Cancer Treatment Drive Buy Rating
30d ago
OLMA
AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright
Premium
The Fly
AstraZeneca data ‘positive’ for Olema’s palazestrant, says H.C. Wainwright
30d ago
AZN
OLMA
Olema Oncology appoints Shawnte Mitchell as Chief Legal Officer
Premium
The Fly
Olema Oncology appoints Shawnte Mitchell as Chief Legal Officer
1M ago
OLMA
Olema Pharmaceuticals Advances in Cancer Therapy Development
PremiumCompany Announcements
Olema Pharmaceuticals Advances in Cancer Therapy Development
2M ago
8K
OLMA
Olema Oncology files $200M mixed securities shelf
PremiumThe Fly
Olema Oncology files $200M mixed securities shelf
3M ago
OLMA
Olema Oncology files to sell 27.53M shares of common stock for holders
PremiumThe Fly
Olema Oncology files to sell 27.53M shares of common stock for holders
3M ago
OLMA
Short Report: Bearish bets on Groupon at record highs
PremiumThe Fly
Short Report: Bearish bets on Groupon at record highs
3M ago
DBI
KSS
Olema Pharmaceuticals Advances Breast Cancer Treatments
PremiumCompany AnnouncementsOlema Pharmaceuticals Advances Breast Cancer Treatments
4M ago
8K
OLMA
Olema Oncology presents updated results for palazestrant
Premium
The Fly
Olema Oncology presents updated results for palazestrant
4M ago
OLMA
Olema Oncology announces FDA clearance of IND for OP-3136
Premium
The Fly
Olema Oncology announces FDA clearance of IND for OP-3136
4M ago
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >